Search results for: “biopharmaceutical”
-
Quantum Genomics announces the end of its collaboration with Chinese Pharma Qilu
•
PARIS: Quantum Genomics announced the end of its collaboration with Chinese Pharma Qilu in the development and the…
-
Sanofi completes acquisition of Kiadis Pharma
•
AMSTERDAM: Sanofi has completed the acquisition of Kiadis, a clinical-stage biopharmaceutical company developing next generation ‘off-the-shelf’ NK cell-therapies,…
-
Cellectis S.A. sells $47 million worth of American Depositary Shares
•
NEW YORK: Cellectis S.A. has completed sales of approximately $47 million of American Depositary Shares (ADS) pursuant to…
-
Exact Therapeutics appoints Dominic Moreland as Chief Financial Officer
•
OSLO: Exact Therapeutics AS announced the appointment of Dominic Moreland as Chief Financial Officer who will be based…
-
Tryp Therapeutics appoints Greg McKee as Chief Executive Officer
•
SAN DIEGO: Tryp Therapeutics Inc. has appointed Greg McKee as its Chief Executive Officer, a news release said.…
-
AstraZeneca US vaccine trial met primary endpoint
•
LONDON: The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing…
-
Xcovery appoint Giovanni Selvaggi as Chief Executive Officer
•
PALM BEACH GARDENS: Xcovery Holdings Inc. announced that Giovanni Selvaggi, M.D., has been appointed as the Chief Executive…
-
Instem plc acquires The Edge Software Consultancy for £8.5 million
•
LONDON: Instem plc, a leading provider of IT solutions, has acquired the entire issued share capital of The…
-
Starpharma signs research agreement with MSD
•
MELBOURNE: Starpharma Holdings has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth…
-
Starpharma Holdings Limited (ASX:SPL)
•
Click Here Starpharma Holdings Limited (ASX:SPL) share price Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company…
-
Oncorus prices public offering of 3.0 million common shares
•
CAMBRIDGE: Oncorus Inc. announced the pricing of its underwritten public offering of 3.0 million shares of its common…
-
AstraZeneca agrees to divest Viela shareholding for upto $780mn
•
STOCKHOLM: AstraZeneca Plc has agreed, subject to certain limited exceptions, to divest its 26.7% ownership in Viela Bio…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.